IDO1 and familial dilated cardiomyopathy: Our data indicated that treatment with two-dose hUCMSCs, particularly with IDO-OE hUCMSCs, was more effective than single-dose therapy for restoring LV function in DCM rats, which were associated with enhancing anti-inflammatory Treg responses and inhibiting pro-inflammatory Th1 and Th17 responses.